Literature DB >> 23509308

Brentuximab vedotin demonstrates activity in a patient with plasmablastic lymphoma arising from a background of chronic lymphocytic leukemia.

Britt M Holderness1, Saurabh Malhotra, Norman B Levy, Alexey V Danilov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23509308     DOI： 10.1200/JCO.2012.46.9593

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

1.  Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.

Authors:  Yusuke Koizumi; Tomoko Uehira; Yasunori Ota; Yoshihiko Ogawa; Keishiro Yajima; Junko Tanuma; Mihoko Yotsumoto; Shotaro Hagiwara; Satoshi Ikegaya; Dai Watanabe; Hitoshi Minamiguchi; Keiko Hodohara; Kenta Murotani; Hiroshige Mikamo; Hideho Wada; Atsushi Ajisawa; Takuma Shirasaka; Hirokazu Nagai; Yoshinori Kodama; Tsunekazu Hishima; Makoto Mochizuki; Harutaka Katano; Seiji Okada
Journal:  Int J Hematol       Date:  2016-09-07       Impact factor: 2.490

Review 2.  Brentuximab vedotin for treatment of non-Hodgkin lymphomas: A systematic review.

Authors:  Garrett K Berger; Ali McBride; Stephanie Lawson; Kelsey Royball; Seongseok Yun; Kevin Gee; Irbaz Bin Riaz; Ahlam A Saleh; Soham Puvvada; Faiz Anwer
Journal:  Crit Rev Oncol Hematol       Date:  2016-11-21       Impact factor: 6.312

Review 3.  Plasmablastic Lymphoma: A Review of Current Knowledge and Future Directions.

Authors:  Ghaleb Elyamany; Eman Al Mussaed; Ali Matar Alzahrani
Journal:  Adv Hematol       Date:  2015-08-18

4.  Human immunodeficiency virus-negative plasmablastic lymphoma in the neck: a rare case report and literature review.

Authors:  Pengli Jiang; Min Liu; Bailong Liu; Bin Liu; Yuhua Zhou; Lihua Dong
Journal:  Eur J Med Res       Date:  2014-11-22       Impact factor: 2.175

5.  Plasmablastic Lymphoma: Case Report of Prolonged Survival of an Advanced Human Immunodeficiency Patient and Literature Review.

Authors:  Hind Rafei; Ehab El-Bahesh; Antoine Finianos; Min-Ling L Liu; Geraldine P Schechter
Journal:  Case Rep Hematol       Date:  2017-09-24

6.  Plasmablastic Lymphoma, a Rare Entity in Bone Marrow with Unusual Immunophenotype and Challenging Differential Diagnosis.

Authors:  Majd Al Shaarani; Rodney E Shackelford; Samip R Master; Glenn M Mills; Yasir AlZubaidi; Ahmed Mamilly; Eric X Wei
Journal:  Case Rep Hematol       Date:  2019-09-02

7.  Bortezomib, Lenalidomide and Dexamethasone Combination Induced Complete Remission in Relapsed/Refractory Plasmablastic Lymphoma: Case Report of a Potential Novel Treatment Approach.

Authors:  Waleed Sabry; Yue Wu; Shruthi Ganeshappa Kodad
Journal:  Curr Oncol       Date:  2022-07-18       Impact factor: 3.109

8.  Plasmablastic Lymphoma Involving Kidney in an HIV Positive Patient: A Case Report with Review of the Literature.

Authors:  Sulav Sapkota; Mona Priyadarshini; Diganta Hazarika; Shivakumar Swamy; Radheshyam Naik
Journal:  Indian J Nephrol       Date:  2021-02-08

9.  Plasmablastic Lymphoma with Coexistence of Chronic Lymphocytic Leukemia in an Immunocompetent Patient: A Case Report and Mini-Review.

Authors:  Eleftheria Hatzimichael; Konstantina Papathanasiou; Ioannis Zerdes; Stefanos Flindris; Alexandra Papoudou-Bai; Eleni Kapsali
Journal:  Case Rep Hematol       Date:  2017-11-20

10.  HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases.

Authors:  Ya-Jun Li; Ji-Wei Li; Kai-Lin Chen; Jin Li; Mei-Zuo Zhong; Xian-Ling Liu; Ping-Yong Yi; Hui Zhou
Journal:  Blood Res       Date:  2020-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.